Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)
82.15
+4.46 (5.74%)
At close: Mar 6, 2026
-4.48% (1Y)
| Market Cap | 21.75B +26.6% |
| Revenue (ttm) | 812.73M +52.5% |
| Net Income | -160.70M |
| EPS | -0.61 |
| Shares Out | 264.71M |
| PE Ratio | n/a |
| Forward PE | 93.18 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,509,120 |
| Average Volume | 3,133,992 |
| Open | 78.29 |
| Previous Close | 77.69 |
| Day's Range | 77.00 - 83.22 |
| 52-Week Range | 75.10 - 134.17 |
| Beta | 0.20 |
| RSI | 41.78 |
| Earnings Date | Mar 28, 2026 |